Physical Activity, High-Sensitivity C-Reactive Protein, and Total and Cardiovascular Disease Mortality in Type 2 Diabetes

被引:31
|
作者
Vepsalainen, Teemu [1 ,2 ]
Soinio, Minna [1 ,2 ]
Marniemi, Jukka [3 ]
Lehto, Seppo [4 ,5 ]
Juutilainen, Auni [4 ,5 ]
Laakso, Markku [4 ,5 ]
Ronnemaa, Tapani [1 ,2 ]
机构
[1] Univ Turku, Dept Med, Turku, Finland
[2] Turku Univ Hosp, FIN-20520 Turku, Finland
[3] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Turku, Finland
[4] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland
[5] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
关键词
CORONARY-HEART-DISEASE; NONDIABETIC SUBJECTS; STRENUOUS EXERCISE; INFLAMMATION; ATHEROSCLEROSIS; RISK; PREVENTION; MARKERS;
D O I
10.2337/dc11-0469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Physical activity reduces high-sensitivity C-reactive protein (hs-CRP), cardiovascular disease (CVD), and total mortality in type 2 diabetic patients. However, it is not known whether the effects of physical activity on mortality depend on the levels of hs-CRP in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS-We prospectively followed-up on 569 type 2 diabetic patients, aged 45-64 years, who were free of CVD at baseline. Participants were stratified according to the level of hs-CRP (<1.0, 1.0-3.0, or >3.0 mg/L) and the degree of physical activity (0-4 metabolic equivalent tasks [METs] or >4 METs). The Cox proportional hazards model was used to estimate the joint association between physical activity and hs-CRP levels and the risk of mortality. RESULTS-During an 18-year follow-up, 356 patients died, 217 of whom died of CVD. Those who were physically more active had significantly reduced total, CVD and coronary heart disease (CHD) mortality among patients with elevated hs-CRP levels (>3 mg/L). These findings persisted in multivariable analyses. However, in patients with an hs-CRP level <1 mg/L or between 1 and 3 mg/L, there was no statistically significant relationship between physical activity and CVD or CHD mortality. CONCLUSIONS-Physical activity reduces total, CVD, and CHD mortality in type 2 diabetic patients with elevated hs-CRP levels. This suggests that the anti-inflammatory effect of physical activity may counteract increased CVD and CHD morbidity and mortality associated with high CRP levels.
引用
收藏
页码:1492 / 1496
页数:5
相关论文
共 50 条
  • [1] High-Sensitivity C-Reactive Protein and Cardiovascular Disease
    Young, Ian
    Rifai, Nader
    CLINICAL CHEMISTRY, 2009, 55 (02) : 201 - 202
  • [2] Physical Activity and High-Sensitivity C-Reactive Protein
    Eric P. Plaisance
    Peter W. Grandjean
    Sports Medicine, 2006, 36 : 443 - 458
  • [3] Physical activity and high-sensitivity C-reactive protein
    Plaisance, Eric P.
    Grandjean, Peter W.
    SPORTS MEDICINE, 2006, 36 (05) : 443 - 458
  • [4] Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality
    Parrinello, Christina M.
    Lutsey, Pamela L.
    Ballantyne, Christie M.
    Folsom, Aaron R.
    Pankow, James S.
    Selvin, Elizabeth
    AMERICAN HEART JOURNAL, 2015, 170 (02) : 380 - U247
  • [5] High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes
    Tajiri, Y
    Mimura, K
    Umeda, F
    OBESITY RESEARCH, 2005, 13 (10): : 1810 - 1816
  • [6] Clinical significance of high-sensitivity C-reactive protein in cardiovascular disease
    Conen, David
    Ridker, Paul M.
    BIOMARKERS IN MEDICINE, 2007, 1 (02) : 229 - 241
  • [7] Serum High-Sensitivity C-Reactive Protein Level Predicts Cardiovascular Events in Chinese Patients with Type 2 Diabetes with No Known Cardiovascular Disease
    Lam, Karen S. L.
    Lee, Paul C. H.
    Woo, Yu Cho
    Chow, Wing Sun
    Fong, Carol H. Y.
    Yuen, Michele M. A.
    DIABETES, 2017, 66 : A1 - A2
  • [8] High-sensitivity C-reactive protein and disease activity in rheumatoid arthritis
    Dessein, P
    Joffe, BI
    Christian, BF
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 398 - 398
  • [10] High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities
    Helfenstein Fonseca, Francisco Antonio
    de Oliveira Izar, Maria Cristina
    CLINICS, 2016, 71 (04) : 235 - 242